Your browser doesn't support javascript.
loading
Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis.
Fazio, Nicola; Buzzoni, Roberto; Delle Fave, Gianfranco; Tesselaar, Margot E; Wolin, Edward; Van Cutsem, Eric; Tomassetti, Paola; Strosberg, Jonathan; Voi, Maurizio; Bubuteishvili-Pacaud, Lida; Ridolfi, Antonia; Herbst, Fabian; Tomasek, Jiri; Singh, Simron; Pavel, Marianne; Kulke, Matthew H; Valle, Juan W; Yao, James C.
Afiliación
  • Fazio N; European Institute of Oncology, IRCCS, Milan, Italy.
  • Buzzoni R; Fondazione IRCCS Foundation, The National Institute of Tumors, Milan, Italy.
  • Delle Fave G; Hospital Sant'Andrea, La Sapienza University, Rome, Italy.
  • Tesselaar ME; Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Wolin E; Montefiore Einstein Center for Cancer Care, Bronx, NY, USA.
  • Van Cutsem E; University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium.
  • Tomassetti P; Department of Medical and Surgical Sciences, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Strosberg J; Moffitt Cancer Center, Tampa, FL, USA.
  • Voi M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Bubuteishvili-Pacaud L; Novartis Pharma AG, Basel, Switzerland.
  • Ridolfi A; Novartis Pharma S.A.S., Rueil-Malmaison, France.
  • Herbst F; Novartis Pharma AG, Basel, Switzerland.
  • Tomasek J; Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Brno, Czech Republic.
  • Singh S; Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Pavel M; Charité University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany.
  • Kulke MH; Dana Farber Cancer Institute, Boston, MA, USA.
  • Valle JW; Institute of Cancer Sciences, The Christie NHS Foundation Trust, University of Manchester, Manchester, UK.
  • Yao JC; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cancer Sci ; 109(1): 174-181, 2018 Jan.
Article en En | MEDLINE | ID: mdl-29055056
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tumores Neuroendocrinos / Everolimus / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2018 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tumores Neuroendocrinos / Everolimus / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2018 Tipo del documento: Article País de afiliación: Italia